113 related articles for article (PubMed ID: 22593246)
21. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.
Brendle A; Lei H; Brandt A; Johansson R; Enquist K; Henriksson R; Hemminki K; Lenner P; Försti A
Carcinogenesis; 2008 Jul; 29(7):1394-9. PubMed ID: 18550570
[TBL] [Abstract][Full Text] [Related]
22. miR-608 rs4919510 C>G polymorphism decreased the risk of breast cancer in an Iranian subpopulation.
Hashemi M; Sanaei S; Rezaei M; Bahari G; Hashemi SM; Mashhadi MA; Taheri M; Ghavami S
Exp Oncol; 2016 Mar; 38(1):57-9. PubMed ID: 27031722
[TBL] [Abstract][Full Text] [Related]
23. Investigation of the 1758G>C and 2880A>G variants within the NCOA3 gene in a breast cancer affected Australian population.
Gabrovska PN; Smith RA; O'Leary G; Haupt LM; Griffiths LR
Gene; 2011 Aug; 482(1-2):68-72. PubMed ID: 21601620
[TBL] [Abstract][Full Text] [Related]
24. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
25. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
[TBL] [Abstract][Full Text] [Related]
27. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
[TBL] [Abstract][Full Text] [Related]
28. The role of polymorphisms in circadian pathway genes in breast tumorigenesis.
Dai H; Zhang L; Cao M; Song F; Zheng H; Zhu X; Wei Q; Zhang W; Chen K
Breast Cancer Res Treat; 2011 Jun; 127(2):531-40. PubMed ID: 20978934
[TBL] [Abstract][Full Text] [Related]
29. SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population.
Han W; Kim KY; Yang SJ; Noh DY; Kang D; Kwack K
Cancer; 2012 Feb; 118(3):594-602. PubMed ID: 21751184
[TBL] [Abstract][Full Text] [Related]
30. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.
Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761
[TBL] [Abstract][Full Text] [Related]
31. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
[TBL] [Abstract][Full Text] [Related]
33. Association of breast cancer-related microRNA polymorphisms with idiopathic primary ovarian insufficiency.
Rah H; Kim HS; Cha SH; Kim YR; Lee WS; Ko JJ; Kim NK
Menopause; 2015 Apr; 22(4):437-43. PubMed ID: 25203895
[TBL] [Abstract][Full Text] [Related]
34. Association of the microRNA-Single Nucleotide Polymorphism rs2910164 in miR146a with sporadic breast cancer susceptibility: A case control study.
Upadhyaya A; Smith RA; Chacon-Cortes D; Revêchon G; Bellis C; Lea RA; Haupt LM; Chambers SK; Youl PH; Griffiths LR
Gene; 2016 Jan; 576(1 Pt 2):256-60. PubMed ID: 26476291
[TBL] [Abstract][Full Text] [Related]
35. Genetic analysis and preliminary function study of miR-423 in breast cancer.
Zhao H; Gao A; Zhang Z; Tian R; Luo A; Li M; Zhao D; Fu L; Fu L; Dong JT; Zhu Z
Tumour Biol; 2015 Jun; 36(6):4763-71. PubMed ID: 25663458
[TBL] [Abstract][Full Text] [Related]
36.
Bahreini F; Ramezani S; Shahangian SS; Salehi Z; Mashayekhi F
Br J Biomed Sci; 2020 Jan; 77(1):29-34. PubMed ID: 31642395
[No Abstract] [Full Text] [Related]
37. Association Between miR-423 rs6505162 Polymorphism and Susceptibility to Cancer.
Moazeni-Roodi A; Ghavami S; Hashemi M
Arch Med Res; 2019 Jan; 50(1):21-30. PubMed ID: 31101240
[TBL] [Abstract][Full Text] [Related]
38. Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study.
Jedlinski DJ; Gabrovska PN; Weinstein SR; Smith RA; Griffiths LR
Twin Res Hum Genet; 2011 Oct; 14(5):417-21. PubMed ID: 21962133
[TBL] [Abstract][Full Text] [Related]
39. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk.
Ye Y; Wang KK; Gu J; Yang H; Lin J; Ajani JA; Wu X
Cancer Prev Res (Phila); 2008 Nov; 1(6):460-9. PubMed ID: 19138993
[TBL] [Abstract][Full Text] [Related]
40. Genetic association analysis of miRNA SNPs implicates MIR145 in breast cancer susceptibility.
Chacon-Cortes D; Smith RA; Haupt LM; Lea RA; Youl PH; Griffiths LR
BMC Med Genet; 2015 Nov; 16():107. PubMed ID: 26577090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
